It has also been found to reduce MM tumor burden in mice when combined with bortezomib [36], as well as to exhibit activity against glioblastoma in rat models [37] and potentiate anti-VEGF therapy against glioblastoma [38]. This evidence concerns the gene VEGFA and glioblastoma.